Lipoprotein(a) testing: what it measures and when to order.

What the test measures

Lp(a) is an LDL-like particle in which apolipoprotein B-100 is bound to a distinctive apolipoprotein(a). Plasma concentration is largely genetically determined and stays relatively stable across the lifespan, so a single measurement usually characterizes a patient for years rather than months.

The assay reports particle concentration. Results are expressed in nmol/L, which reflects particle number, or in mg/dL, which reflects mass on some older methods. Because particle size varies between individuals, nmol/L is generally preferred for comparing patients on a consistent scale.

When clinicians may consider ordering

Lp(a) is not part of a routine lipid panel, and because it is largely fixed, most patients need it only once unless a specific clinical question arises. Clinicians commonly consider it to refine risk in situations such as:

• a personal or family history of premature atherosclerotic cardiovascular disease;
• atherosclerotic disease that progresses despite well-managed LDL-C;
• a known family history of elevated Lp(a);
• borderline decisions where an added, independent risk marker would sharpen the picture.

Because concentration is inherited, an elevated result in one patient can prompt a conversation about testing first-degree relatives. Whether to pursue that is a clinical judgment for the provider.

Interpreting the result

The reference range applied by our national laboratory network is <75 nmol/L. Values above the range are generally regarded as conferring incremental cardiovascular risk that tends to rise with concentration. Lp(a) is a risk marker rather than a diagnosis: it contextualizes global risk alongside the standard lipid panel, ApoB, and the clinical history.

A single value is usually sufficient given the stability of Lp(a) over time. Ordering, interpretation, and any resulting management remain the responsibility of the licensed provider, and nothing here is a treatment recommendation.

Practical notes for ordering

The test uses a serum specimen and calls for a 10–12 hour fast. Turnaround is typically several business days, so it fits naturally into a scheduled cardiovascular workup rather than a same-visit decision. Patients can complete the draw at CLIA-certified sites nationwide, and results return to the ordering provider for review.

Because Lp(a) rarely needs repeating, it pairs well with a one-time baseline risk assessment. For the broader lipid picture, ApoB is a natural companion measure; see the ApoB guide for how the two fit together.